If you are in receipt of a Transfer of Value from us from 1st September 2022, we will be using Legitimate Interest as the legal basis for processing and sharing your personal details with the ABPI so that we can comply with our obligations under the Code of Practice for the Pharmaceutical Industry.
We will no longer be asking for your consent because we strongly feel there is a legitimate public interest in better understanding the financial relationships that individuals may have with us, in the interests of transparency and trust in the pharmaceutical industry.